PortfoliosLab logo

Atara Biotherapeutics, Inc. (ATRA)

Equity · Currency in USD · Last updated Dec 8, 2022

Company Info

ISINUS0465131078
CUSIP046513107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.66
Year Range$2.85 - $17.31
EMA (50)$4.43
EMA (200)$7.13
Average Volume$1.30M
Market Capitalization$425.06M

ATRAShare Price Chart


Loading data...

ATRAPerformance

The chart shows the growth of $10,000 invested in Atara Biotherapeutics, Inc. in Oct 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,376 for a total return of roughly -56.24%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
-10.71%
0.85%
ATRA (Atara Biotherapeutics, Inc.)
Benchmark (^GSPC)

ATRACompare to other instruments

Search for stocks, ETFs, and funds to compare with ATRA

ATRAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-1.89%4.33%
6M-17.81%-5.45%
YTD-70.43%-17.46%
1Y-72.56%-14.32%
5Y-19.43%8.34%
10Y-9.66%9.63%

ATRAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-2.54%-16.34%-27.70%-31.54%-18.24%49.81%-61.10%32.34%-5.74%23.28%-2.79%2.87%
2021-5.96%-9.10%-14.42%-2.09%-3.56%14.68%-18.01%17.49%19.49%-13.52%15.57%-11.91%
2020-19.67%-8.16%-29.96%-2.59%38.72%26.70%-14.96%8.80%-3.86%-0.39%79.63%-15.35%
20199.38%-5.76%11.00%-15.47%-33.90%-9.46%-29.04%-5.40%4.59%-22.66%30.13%15.90%
2018108.84%1.92%1.23%3.46%23.42%-26.20%2.18%9.05%0.98%-17.36%16.92%-13.04%
2017-5.28%14.87%33.01%-16.79%-22.51%5.66%8.93%3.28%5.08%-14.20%1.76%25.26%
2016-31.47%-9.17%15.75%-5.36%0.56%24.30%6.62%-18.58%9.47%-40.16%55.08%-28.46%
2015-8.93%-19.70%112.53%-0.29%2.20%24.55%6.41%-27.81%-22.43%-18.03%52.50%-32.80%
201480.09%40.77%-0.93%

ATRASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Atara Biotherapeutics, Inc. Sharpe ratio is -0.65. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20JulyAugustSeptemberOctoberNovemberDecember
-0.65
-0.67
ATRA (Atara Biotherapeutics, Inc.)
Benchmark (^GSPC)

ATRADividend History


Atara Biotherapeutics, Inc. doesn't pay dividends

ATRADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-92.72%
-17.98%
ATRA (Atara Biotherapeutics, Inc.)
Benchmark (^GSPC)

ATRAWorst Drawdowns

The table below shows the maximum drawdowns of the Atara Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Atara Biotherapeutics, Inc. is 95.55%, recorded on Aug 1, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.55%Apr 24, 20151831Aug 1, 2022
-43.4%Dec 3, 201450Feb 13, 201518Mar 12, 201568
-21.57%Nov 10, 20143Nov 12, 201413Dec 2, 201416
-10.42%Mar 24, 20153Mar 26, 20152Mar 30, 20155
-7.46%Oct 21, 20143Oct 23, 20141Oct 24, 20144
-7.11%Oct 29, 20141Oct 29, 20143Nov 3, 20144
-6.34%Mar 31, 20152Apr 1, 20151Apr 2, 20153
-5.13%Mar 13, 20151Mar 13, 20152Mar 17, 20153
-4.65%Mar 18, 20151Mar 18, 20151Mar 19, 20152
-3.5%Apr 6, 20151Apr 6, 20152Apr 8, 20153

ATRAVolatility Chart

Current Atara Biotherapeutics, Inc. volatility is 72.87%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%JulyAugustSeptemberOctoberNovemberDecember
72.87%
22.83%
ATRA (Atara Biotherapeutics, Inc.)
Benchmark (^GSPC)